prediction (including prognosis), discrimination (dis-
ON THE USES OF ROUTINE PATIENT-REPORTED HEALTH OUTCOME DATA
β Scribed by Peter C. Smith; Andrew D. Street
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 419 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.2793
No coin nor oath required. For personal study only.
β¦ Synopsis
ABSTRACT
It has long been standard practice to ask patients in clinical trials about their health status, but the practice is now being extended to patients receiving treatment on a routine basis. In this paper, we examine four types of analyses that these health data might inform: comparisons of alternative treatments for the same condition, of health care providers, of changes in performance over time and of treatments of different types of condition. Analytical challenges arise because counterfactuals cannot be observed and because health status cannot be measured continuously. The implications of these challenges and the ability to meet them vary according to the comparative exercise. We argue that, provided with a sufficient number of health status measures for each patient and proper risk adjustment, health status measurement has great potential to inform the first three types of comparison. However, we believe that it is not yet possible to use such data to make secure comparative judgements about the outcomes from treatment for different types of condition. Copyright Β© 2012 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
Using a multiattribute approach embodied in a 15-item self-assessment William Furlong, M
The natural history of chronic lymphocytic leukemia (CLL) is changing, although the reasons (potential changes in the disease's biology or in patterns in patient characteristics, treatment, or referral) are unclear. ## METHODS. This report uses National Cancer Data Base (NCDB) data, which reflect
The Dose-Response and Phase Models are useful for informing quality assurance research on the expected patterns for separate categories of outcomes in psychotherapy. Moreover, these models predict the sequence of change for outcomes that may be differentially valued by patients, therapists, stakehol
## Abstract ## BACKGROUND. Healthβrelated quality of life (HRQOL) has not been adequately measured in bladder cancer. A recently developed reliable and diseaseβspecific quality of life instrument (Bladder Cancer Index, BCI) was used to measure urinary, sexual, and bowel function and bother domains
The role of personal expectations on reports of health-related quality of life (HRQL) in the context of a set of other variables commonly thought to affect patient report of HRQL was examined. The complete set of predictor variables included: (1) patient factors including age, gender, race, educatio